USE OF EXTENDED-RELEASE PRAMIPEXOLE IN EARLY-STAGE PARKINSON’S DISEASE: DESCRIPTION OF A CLINICAL CASE
<p>The paper considers a clinical case of early-stage mixed Parkinson’s disease (PD) with significant affective disorders and restless legs syndrome. Once-daily extended-release pramipexole 3 mg significantly improved a patient’s status and led to regression of movement and affective disorders...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2014-11-01
|
| Series: | Klinicist |
| Subjects: | |
| Online Access: | http://klinitsist.abvpress.ru/index.php/Klin/article/view/152 |
| Summary: | <p>The paper considers a clinical case of early-stage mixed Parkinson’s disease (PD) with significant affective disorders and restless legs syndrome. Once-daily extended-release pramipexole 3 mg significantly improved a patient’s status and led to regression of movement and affective disorders. The paper gives data on the efficacy of dopamine receptor agonists in treating PD and the benefits of their extended-release formulations.</p> |
|---|---|
| ISSN: | 1818-8338 |